A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Study to Assess the Efficacy and Tolerability of MK-8141 in Hypertensive Patients

Trial Profile

A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Study to Assess the Efficacy and Tolerability of MK-8141 in Hypertensive Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2013

At a glance

  • Drugs MK 8141 (Primary) ; Enalapril
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 18 Jul 2008 Status changed from recruiting to completed, from clinicaltrials.gov record.
    • 07 Jan 2008 Updated location and trial centres.
    • 05 Dec 2007 Dosing has been started.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top